MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed Patient-Reported Functional Benefit in Treating ...
Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...
X-ray phase-contrast imaging techniques have emerged as a powerful supplement to conventional absorption-based methods, allowing researchers and clinicians to visualise soft tissues and subtle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback